Cytosorbents (CTSO)
(Delayed Data from NSDQ)
$1.13 USD
+0.01 (0.89%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $1.13 0.00 (0.00%) 6:22 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | 11.11% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.31 |
Next Year | -0.08 |
EPS (TTM) | -0.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.14M | 10.69M | 40.53M | 47.13M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 10.48M | 11.17M | 41.33M | 49.76M |
Low Estimate | 9.80M | 10.20M | 39.72M | 44.49M |
Year ago Sales | 8.81M | 8.67M | 36.35M | 40.53M |
Year over Year Growth Est. | 15.10% | 23.24% | 11.49% | 16.29% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.05 | -0.31 | -0.08 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.08 | -0.05 | -0.33 | -0.12 |
High Estimate | -0.05 | -0.05 | -0.29 | -0.04 |
Low Estimate | -0.08 | -0.05 | -0.33 | -0.12 |
Year ago EPS | -0.21 | -0.12 | -0.64 | -0.31 |
Year over Year Growth Est. | 66.67% | 58.33% | 51.56% | 74.19% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.05 | -0.31 | -0.08 |
7 Days Ago | -0.07 | -0.06 | -0.32 | -0.15 |
30 Days Ago | -0.07 | -0.06 | -0.32 | -0.15 |
60 Days Ago | -0.08 | -0.07 | -0.33 | -0.17 |
90 Days Ago | -0.08 | -0.08 | -0.36 | -0.21 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.07 | -0.05 | -0.31 | -0.08 |
Zacks Consensus Estimate | -0.07 | -0.05 | -0.31 | -0.08 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.12 | -0.12 | -0.21 | NA |
Estimate | -0.09 | -0.12 | -0.14 | -0.12 | NA |
Difference | 0.01 | 0.00 | 0.02 | -0.09 | -0.02 |
Surprise | 11.11% | 0.00% | 14.29% | -75.00% | -12.40% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more